This discussion has become a moot point across sectors in India Inc., as promoters are looking at the next generation to not ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of ...

Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...

Though the first chapter of Adult Swim’s Common Side Effects animated series is about to wrap up this Sunday, the story isn’t ...

If you believe the political rhetoric, you probably think America’s industrial base has been hollowed out, gutted or “shipped ...

The new recipients of 23andMe’s data would not necessarily have to offer consumers the ability to opt out once they take possession of it. And it remains unclear which (or how many) hands the data ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Learn more about Ascentage Pharma Group International's (AAPG) stock grades for Value and Growth and determine whether this Biotechnology stock meets your investment needs.

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...